<img src="https://ml.globenewswire.com/Resource/Download/8de285a8-2fd4-4052-87de-8a038c5ba2f1?size=2" nborder="0" align="left" hspace="5" vspace="5" title="Restem-cropped-1024x350-1.png" alt="Restem"/>MIAMI, June 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, Andres Isaias, will participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference, taking place June 30 – July 1, 2026. <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:40%; width:40%; min-width:40%;;text-align: left ; vertical-align: middle; vertical-align: top ; ">Presentation Details:</td><td style="max-width:60%; width:60%; min-width:60%;;text-align: left ; vertical-align: middle; vertical-align: top ; "> </td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">Date and Time: </td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">Tuesday, June 30, 2026</td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">Format:</td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">Corporate presentation and one-on-one meetings</td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">Webcast:</td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "><a href="https://www.globenewswire.com/Tracker?data=IpZIpWHVWKQY1b5VfZPRbtVt7j7SjSEMHgTvc3LySo07L7ggN0drixcHDdKCjo6jItHlRtwGLLX3iCa0yxB7zNcuqwf40Gw1bltcGwymhfCjUN5AAKUq_coGoHm5Q2aaqtBcEZV-EtHPhblVk-QRhA==" rel="nofollow" target="_blank" title="Click here">Click here</a>, available on June 30 at 11:00 AM</td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">Registration:</td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "><a href="https://www.globenewswire.com/Tracker?data=IpZIpWHVWKQY1b5VfZPRbtdGY-EKs-DgrYgriZgO4TABkY9c1XJc9uzLXqDj8SlDkMNTKPZkW0g3SkSZe7QeqspbcHJEAURZLgZ9T3LdsRszvk7Qz_s6HFDV3nkq68MN8JfQcQ3duP-RXnrzegfmWUB1OyisqW4ksPIyxPRK9kxcoJAjrV352R8DUUDjVou7l2yhtDGDtbV800m3EbX6Vg==" rel="nofollow" target="_blank" title="Click here">Click here</a></td></tr><tr><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td><td style="text-align: left ; vertical-align: middle; vertical-align: top ; "> </td></tr></table> A live webcast of the presentation will be available on the Investors section of RESTEM's website at www.restem.com. An archived replay will be available for approximately 30 days following the event. About RESTEM RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies for autoimmune, inflammatory, and age-related diseases. Leveraging proprietary products, deep clinical expertise, and advanced manufacturing capabilities, RESTEM is advancing two potentially transformative programs, Restem-L, our umbilical cord lining progenitor cells (UMPCs) therapy for autoimmune diseases, and activated natural killer cell (aNK) therapeutics targeting senescence and age-associated disorders.  Our therapies are designed to reprogram the immune system rather than focusing solely on symptom management, offering patients with limited options the potential to address underlying disease mechanisms. RESTEM is headquartered in Miami, Florida. For more information, please visit <a href="https://www.globenewswire.com/Tracker?data=FRANMmQR_s3_khOKmLA81CnzD-xHtRbuai94WwBJDoohfNkuEGl6a2zATECgKIc3C5Mul9jSIGU_NWAGMtuNpTP_tjAMAgNx9jkOfCj2kMVvUsuoebvIXISE5y7gPUy6j6BBa6XB2Xcw_GawA4UyTdTtobnVBd9wnEpQ-5JeeGcilEG6c8bxtqMQSrS1-0EewlPUILw40X-1GkzGSpbJbkT3_t1ZT4ZA0m8TyaHnsDqYQkNcdBRsI3Xcvb7KvfXVBSo31rGkAtrZiHJ4aicvSkhIm_t9ZvjV9tkF3P1eOKxCSAXoNy7nhFjMwvgFRknw_J0DYic554fsKemM-ikyOLMesRzVzfSfGcqEL_fRXu8I18pv4OV2wra5pNssXSxe4FkeM6fgjw_JBVBwj3xcxTet67ejXws9s7619x_FvVUFh_aaLdrSqkxN0LVJ4YmKSvBnM3gUkSyT9sm1MlXpfgSZuzTvkADFHmj5i-ZOlslnm-EFetnBaMiFTsakpnuPfO84xzmbYk2fxiZB5ymwv8CfjV4KsDG9xVcx-kwEvC56T59HiZukp0YDqPxFJgyJcSC2uG2ugnlsoNPiLXUf_hW_V6f_dTMzyrWBn9SNb9VEB4bgV7SnXb_tuQt-RtYv9ip7Rm0eb0hGe_aTe0UAAq_GH5OUk_uxNdmMD41YsKs=" rel="nofollow" target="_blank" title="www.restem.com">www.restem.com</a> and follow us on <a href="https://www.globenewswire.com/Tracker?data=vUMbPQM-RQela4YpzDWg7x3_WTbtQ93psnO4gr-6U1hHpUk_T_MAvfhUMlI84xMQzXvu8pRUsHzTHxV_e4Te5JHddr8HLNiu9VZ65UTwAvruuXdY8-GevfSbbV2jpwV5O4pqOfNpolRFOkAm66R48P_QerjZLxY5rxAki5lu4FRg7T9Jxc0jrlq1yeOZKG0qv5HRFvbeVxOQ4xMxhRpQ7NwfPZhsvhS8flghAk56NJgccuZlzUwdSlvI8tmlc828AcSRjf4AeZ98nu8Z6h8V6Q_rQkNEvNSJeqoAHsz5OJnMogdCMkwU_vxRmrDzDsWYWxpGT4lbbjPnKJZYgoebU6mDxiOKdVsQGRf6e_5kO-ICYJW1VQC-FyIwqhpiJxWD6WN5nFrIBMQG8zwCKhIm7xwZAZO8etPKZLsq7LTP6tbtMsH3VF1IROTj3Gq6DOQ865ZCQgRJfbUbyGSSQjXsxjIPexdNCjEFg28VKomH1ROi04CajZtBdn5QZDiJVtxTnIwJBdaKTCkFlIzPKy8JjZmx9FW-G89FF3Fyid2nT7Ot3fPCjR6WwKir44lW9yKcoLAyHOVPApS5tUZHvDXbyVp12TPLsNcWduAzG_qK9g4el3Fm5gCJbz0H_j_EkJwCVMr84UUs83lcZ8Sbft5OyzUdBCi3qqLZON7un9hipndG9gWpdArp0WW5T21H3h7Ue0_D57YxcypLfgCFCxcgkC3saQi7_AKgl6NCTkHmON05y7PhkPcroB18pZlfH7INrzNBFjY1upHTN-PUKE0fOwOCJmuddx4mt-6uVqM89h87-46orbbQOHqBpKzPdHvQ63eizkITV__C7TzBWs_yuAqCV5jzTi6rRuHDzVQ76A56qy1SPvM2Kp_kxqafjnimf_0YV8tYkAvI77IABCa2JS1UxFwWRY8yj7pCvMCTq2c=" rel="nofollow" target="_blank" title="X">X</a> and <a href="https://www.globenewswire.com/Tracker?data=TQp3Ve64T0pZcOh6P98fddqmL84USUGxy9F1zIfbjb8Z3sdBhCrE4JXgKlr1cSBmhxB20SDA-aaeS9keYDfaYuLBt8fCiI_bfcKxqJV9uGbISPzfVi8gkz1rLkFSGRfF7z69644XZJtBTzLGDvFxz5iZbltNKLn37UfGnHs-m9iVxyUHMYbZWDum4AZxkPORSsfTlFpCUrzLr2oy63jsMkJxq2Os2hNY2gJcnEl7oQAaCLAO9zrs48bO5iuJi9wfQGQj_orQHO_8fpf688MYzXqO0stR3Tibi8SQdL_9MC0xF_D2TfkqOAwIfnQ4fVrr3kDf83IJ5iKvo3D5z0nncvg_8ZwVrFkulGMnSyoZdwMlhdzCVDZkDfYR4a2jo2aPnH34aClBjPy_Ym0pWjX0BCrBcvbbKjTD2GvswuOpbWC6LAJzBLHz8Jrap5DER6F7f21nL2TLPebSHCtKLIPf0D-bIX00kv4mvQYNUfprBBeaxpKiNmmFiACibromfqFg5dt-MwHveixdmnYQZE6ziBSbWsgOrSaJf9RDG9dnH9N8HgHM5Jnh_fxrwdX2enBgF7sBu8MQ5UZ2YxU4r_QVsLjDI7Oa58ujHawuaBFtF7X5hCKYr6Ah75B8Yxck9Hk8ZTkhRggdFrkI-jqW2PvsM6b3yHLdUebtWuPiGu_jt5xGmiibx0YYiZpYVth6gYa66_EjlrKGWQQQOje0khaXMtkkV2Inbwt4juBBKTd6iF9plm7R44yyBJ5ctrNYqS1NQNKj_mB8sLMT488smJfilJljU4I5Ds8NCq3w0HWn8OpuapuEe-qcRMWGJq3OSb-8yur_psBiuyZSXFO0S4ZmCJ5rfJ4lJdl0tqZMYyKVB29LewOvqUVAfpp-pdwbrhrnxHmDYo0-S-V6i0-bA-Au4NCYyEGEIQ781cFZ5kD_y9GXVEWsdisRrmK2d-ljtQA_ePu9o2vsnCzxt6rEVo3yToDiz733n5HsfSv2fWsSwA0iac97RGg7xZ7RyVvLHtLLQw29FUscMp6ToyBv9JH8RQ==" rel="nofollow" target="_blank" title="LinkedIn">LinkedIn</a>. Investor Contact Daniel Ferry LifeSci Advisors +1.617.430.7576 daniel@lifesciadvisors.com Media Contact Nelson Cabatuan Restem Group, Inc. +1.800.490.0924 ncabatuan@restem.com <img alt="" src='https://ml.globenewswire.com/media/NzdlNjE5MzAtNmM2ZS00NTQ2LWE2MTMtZTJlZWM0ZjFhODgzLTUwMDEzMDA2Ni0yMDI2LTA2LTIzLWVu/tiny/Restem.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn